Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment
Clinical trial NCT04343287 · COMPLETED
Trial details
- NCT number
- NCT04343287
- Sponsor
- BRIM Biotechnology Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-15
- Primary completion
- 2020-06-23
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.